Mr. Fischer currently serves as a member of the Board of Directors of Marinus Pharmaceuticals, Inc. (MRNS), Agile Therapeutics, Inc. (AGRX), and is also an advisor to MedHab, LLC. Previously, Mr. Fischer served as the Chief Executive Officer and as a Director of Vivus, Inc., a publicly traded biopharmaceutical company commercializing and developing innovative, next-generation therapies to address unmet needs in obesity, diabetes, sleep apnea and sexual health from September 2013 to December 2017.
Prior to Vivus, Mr. Fischer served in various positions of increasing responsibility at Johnson & Johnson, most recently as company Group Chairman, Johnson & Johnson and Worldwide Franchise Chairman of Cordis Corporation. Prior to that, he served as company Group Chairman, North America Pharmaceuticals, which included responsibilities for Ortho-McNeil Pharmaceuticals, Janssen and Scios. Prior to that, Mr. Fischer served as President of Ortho-McNeil Pharmaceuticals. Mr. Fischer’s operating responsibilities encompassed the commercialization of products in multiple therapeutic categories including neurologic products for epilepsy and migraines and products in the analgesic, anti-infective, cardiovascular, psychiatric and women’s health areas. From May 2013 to May 2019, Mr. Fischer also served on the Board of Directors of BioSig Technologies, Inc.
Mr. Fischer brings to the Board over 37 years of experience in the pharmaceutical industry, including 29 years in various leadership roles at Johnson & Johnson.
What is Seth H.Z. Fischer's net worth?
The estimated net worth of Seth H.Z. Fischer is at least $6,206.78 as of February 6th, 2023. Mr. Fischer owns 6,026 shares of Spectrum Pharmaceuticals stock worth more than $6,207 as of April 25th. This net worth evaluation does not reflect any other investments that Mr. Fischer may own. Learn More about Seth H.Z. Fischer's net worth.
How do I contact Seth H.Z. Fischer?
Has Seth H.Z. Fischer been buying or selling shares of Spectrum Pharmaceuticals?
Seth H.Z. Fischer has not been actively trading shares of Spectrum Pharmaceuticals during the last ninety days. Most recently, Seth H. Z. Fischer sold 5,711 shares of the business's stock in a transaction on Tuesday, June 21st. The shares were sold at an average price of $0.79, for a transaction totalling $4,511.69. Following the completion of the sale, the director now directly owns 29,066 shares of the company's stock, valued at $22,962.14. Learn More on Seth H.Z. Fischer's trading history.
Who are Spectrum Pharmaceuticals' active insiders?
Are insiders buying or selling shares of Spectrum Pharmaceuticals?
During the last twelve months, insiders at the biotechnology company sold shares 1 times. They sold a total of 32,387 shares worth more than $35,625.70. The most recent insider tranaction occured on May, 26th when CFO Nora Brennan sold 32,387 shares worth more than $35,625.70. Insiders at Spectrum Pharmaceuticals own 2.7% of the company.
Learn More about insider trades at Spectrum Pharmaceuticals. Information on this page was last updated on 5/26/2023.
